Mergers & Acquisitions - Mergers & Acquisitions, Generics, Financial

Filter

Indian pharmaceutical sector to see strong growth, says Moody’s

Indian pharmaceutical sector to see strong growth, says Moody’s

25-08-2014

Moody's Investors Service says that India's pharmaceutical market will continue to grow in the double…

FinancialGenericsIndiaMarkets & MarketingMergers & Acquisitions

Abbott Labs sells branded generics business to Mylan in $5.3 billion deal

Abbott Labs sells branded generics business to Mylan in $5.3 billion deal

14-07-2014

Following a weekend of rumors and speculation, USA-based generics major Mylan and health care firm Abbott…

Abbott LaboratoriesAustraliaCanadaEuropeFinancialGenericsJapanMergers & AcquisitionsMylanNew Zealand

AMRI to acquire Cedarburg Pharmaceuticals in $41 million deal

24-03-2014

Albany Molecular Research, a USA-based contract research and manufacturing organization, has signed a…

Albany Molecular ResearchCedarburg PharmaFinancialGenericsMergers & Acquisitions

Stada Arz buys UK OTC manufacturer

21-08-2013

German generic and branded drugmaker Stada Arzneimittel (SAZ: GR) signed and concluded a contract for…

FinancialGenericsMergers & AcquisitionsPharmaceuticalSTADA ArzneimittelThornton & Ross

Actavis and Warner Chilcott leap on merger talks; possible bid for Adcock Ingram

13-05-2013

US generics major Actavis NYSE: ACT) confirmed on Friday (May 10) that it has entered into early stage…

ActavisAdcock IngramFinancialGenericsMergers & AcquisitionsPharmaceuticalWarner Chilcott

Hikma to retain its global Injectables business

17-04-2013

Further to its announcement last month that it was undertaking a review of the strategic options for…

FinancialGenericsHikma PharmaceuticalsMergers & AcquisitionsPharmaceutical

Hikma leaps as it confirms unsolicited interest in Injectables business

04-03-2013

Jordanian drugmaker Hikma Pharmaceuticals (LSE: HIK) saw its shares jump 8.1% to£9.365 on Friday,…

FinancialGenericsHikma PharmaceuticalsMergers & AcquisitionsPharmaceutical

Mylan signs $1.6bn deal to buy Agila injectables division

28-02-2013

Agila SpecialitesFinancialGenericsMergers & AcquisitionsMylan Laboratories

Pernix splashes out over $100 million to buy Cypress Pharma and Hawthorn Pharma

15-11-2012

US specialty drugmaker Pernix Therapeutics (NYSE: PTX) has entered into a definitive agreement to acquire…

Cypress PharmaceuticalsFinancialGenericsHawthorn PharmaceuticalsMergers & AcquisitionsPernix TherapeuticsPharmaceutical

Fitch puts Watson on rating watch Negative on planned acquisition of Actavis

26-04-2012

US generics drugmaker Watson Pharmaceuticals (NYSE: WPI) has seen its rating downgraded by Fitch Ratings,…

ActavisFinancialGenericsMergers & AcquisitionsNorth AmericaWatson Pharmaceuticals

Valeant Pharma to acquire assets in Mexico; Mylan invests in Ireland

19-04-2012

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) says it has signed an…

Atlantis PharmaEuropeFinancialGenericsMergers & AcquisitionsMylan LaboratoriesSouth AmericaValeant Pharmaceuticals

Flamel Tech acquires US firm Eclat Pharma; reports loss

19-03-2012

Lyon, France-based drug delivery firm Flamel Technologies (Nasdaq: FLML) said last week that it has acquired…

Eclat PharmaceuticalsFinancialFlamel TechnologiesGenericsMergers & AcquisitionsPharmaceutical

Watson buys Strides Arcolab unit for A$375 million; 2011 results

24-01-2012

US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) has kicked off the new year with the acquisition…

Ascent PharmahealthAsia-PacificFinancialGenericsMergers & AcquisitionsStrides ArcolabWatson Pharmaceuticals

STADA to buy Spirig generics business for $109 million; posts 9-month loss due to Serbian difficulties

11-11-2011

German drugmaker STADA Arzneimittel (SAZ: GR) has reached agreement with Switzerland’s Spirig Pharma…

FinancialGenericsMergers & AcquisitionsPharmaceuticalSpirig PharmaSTADA Arzneimittel

Aurobindo sets up JV with Diod to make and market generic drugs in Russia

09-09-2011

Indian drugmaker Aurobindo Pharma (ARBN: BO) and OJSC Diod, a Russian manufacturer of ecological health…

Aurobindo PharmaDiodEuropeFinancialGenericsMarkets & MarketingMergers & Acquisitions

Company Spotlight

ImmunoGen

ImmunoGen

Back to top